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Background: The observed controversy that N-(4-cyanophenylmethyl)-4-(2-diphenyl)-1-piperazinehexanamide
(LP-211), a selective serotonin (5-HT7) receptor agonist, may either modify or exacerbate imbalances in serum
electrolyte concentrations and renal tissue of spinal cord trauma cases has not been reported yet. The aim of this
study was to better understand the effects of a new 5-HT7 receptor agonist, LP-211, on serum electrolyte changes
in spinal cord injured- (SCI) rats.
Methods: Sixty male rats were assigned to the following groups: A) Intact (saline as vehicle, 1 ml/kg, i.p.), B) Intact
[LP-211, (0.003–0.3 mg/kg, i.p.)], C) Sham-operated [laminectomy + vehicle (1 ml/kg, i.p.)], D) Sham-operated
[laminectomy + LP-211 (0.003–0.3 mg/kg, i.p.)], E) Treatment [laminectomy + spinal trauma (SCI) + vehicle (1 ml/kg,
i.p.)], F) Treatment [laminectomy + spinal trauma + LP-211 (0.003–0.3 mg/kg, i.p.)]. SCI was performed by placing an
aneurysm clip, extradurally at the level of T10. After two weeks, LP-211 was administered cumulatively and each
dose was injected (i.p.) with 20 min interval. At the end of the experiment, blood samples were collected for
biochemical evaluations of the electrolytes employing standard commercial kits.
Results: The present results indicate elevated serum levels of Na+, K+, and Mg2+ in SCI rats and significant
differences demonstrated between the groups [P < 0.001, F(5, 35) = 23.92], [P < 0.001, F(5, 35) = 67.63], [P < 0.001,
F(5, 35) = 71.144], respectively. So that, in groups B, D and F, there was a significant increase in K+ and Mg2+ serum
levels compared to the groups A, C, and E (P < 0.001). Furthermore, Na+ serum levels in SCI (LP-211), laminectomy
(LP-211), and intact (LP-211) groups tended to be statistically lower than SCI (saline), laminectomy (saline) and intact
(saline) groups. Infact, hyponatremia, hyperkalemia and hypermagnesemia was obtained in group F. Nevertheless, in
the remaining measured serum electrolytes such as calcium (Ca2+), iron (Fe2+) and phosphorus (P3−), chlorine (Cl−),
copper (Cu+), and zinc (Zu+), no significant changes were observed.
Conclusion: It was shown that acute additive LP-211 treatments in the SCI group led to hyponatremia,
hyperkalemia and hypermagnesemia, it may be stated that LP-211 treatment as a promising candidate for treating
SCI complications in some systems especially urinary tract might take into consideration and further studies would
be needed to clarify its benefits or drawbacks. The observed discrepancies, nevertheless; will also pose new
questions. Altogether, this will ultimately contribute to further understanding the pathophysiological role regarding
5-HT7 receptor activation.R
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Traumatic spinal cord injury (SCI) is a major clinical
problem with permanent neurological deficits and a
broad range of secondary complications [1]. The patho-
physiology of acute SCI involving primary and secondary
mechanisms of injury is highly complex and not clearly
understood. Primary events occur at the time of trauma
and related to mechanical damage and after primary in-
jury, further pathophysiological processes such as hypoxia,
edema and inflammation, altered blood flow and changes
in microvascular permeability are triggered; thus, lesions
greatly enlarge and worsen by secondary injury [2, 3]. Sec-
ondary events develop hours to days after trauma, which
includes a cascade of biochemical and cellular processes,
such as electrolyte abnormalities, formation free radicals,
vascular ischemia, edema, posttraumatic inflammatory re-
action together with demyelination and further cell death
by necrotic and apoptotic pathways [4–6]. In parallel,
several studies have revealed that one consequence of
trauma to the spinal cord is an increase in lipid peroxi-
dation and a decrease in the activity of the critical
membrane-bound enzymes such as Na+-K+-activated
ATPase and Na+-K+/Mg+2 ATPase [7–10].
Nowadays, much attention has been focused on the
biochemical changes of secondary injury in spinal cord
trauma. In parallel to, the degree of exchange of Na+, K+
and Mg2+ between tissues and plasma varies greatly. So
that, most studies have shown changes in intracellular
Mg2+ concentration over the physiologic-pathophysiologic
range would significantly affect K+ secretion. Furthermore,
in SCI intracellular effects of Mg-ions are opposite to Ca-
ions in competition at K-ion channels, in Na+-K+/Mg+2
ATPase activity, cAMP/cGMP concentration and Ca-ion
currents in pre- and postsynaptic membranes [11, 12]. To
support this idea, multiple studies have demonstrated that
traumatic spinal injury causes a decrease in intracellular
free potassium and magnesium concentrations, which cor-
related with injury severity, and is associated with a de-
crease in total tissue K+ and Mg2+concentrations [13–16].
The 5-HT7 receptor was the last member of the 5-HT
receptor family to be identified and was cloned inde-
pendently by three laboratories in 1993 [17, 18]. These
primary studies demonstrated that the 5-HT7 receptor
is positively coupled to adenylate cyclase through the
stimulatory Gs protein, with a pharmacological profile
distinct from that of all other 5-HT receptors [19].
Pharmacological and genetic tools targeting the 5-HT7
receptor in animal models have implicated this recep-
tor in various pathophysiological processes, including:
regulation of body temperature [20], circadian rhythms
[21], learning and memory [22]. Inflammatory pro-
cesses in the CNS [23], smooth muscle relaxation of





The Na+-K+ pump is a ubiquitous membrane protein
that catalyzes the active transport of K+ into cells and
Na+ out of cells against their electrochemical gradient.
Na+-K+ pump activity is regulated by a variety of hor-
mones, neurotransmitters, and growth factors. 5-HT, in
particular, activates the Na+-K+ pump in the brain [28],
kidney [29], and vascular smooth muscle [30]. Indeed,
stimulation of the Na+-K+ pump by 5-HT has been pro-
posed to mediate the inhibitory effect that 5-HT exerts
on vascular smooth muscle tone [31–33]. The cellular
mechanism for 5-HT-induced contraction of airway
smooth muscle has been well characterized and is simi-
lar to that of other contractile receptor agonists. 5-HT
interacts with specific receptors to stimulate inositol
phosphate metabolism, Ca2+ mobilization, and protein
kinase C activation [34–38]. In contrast, the mechanism
of relaxes vascular smooth muscle by 5-HT via 5-HT7 re-
ceptors is unknown.
In recent years, considerable efforts have been focused
on the development of selective 5-HT7 receptor agonists
and antagonists [39, 40]. Although the effects of selective
5-HT7 agonism/antagonism have been studied in several
animal models where it has been shown to have anxio-
lytic [41–43], antidepressant [44–46], antipsychotic-like
hyponatremia, hyperkalemia and hypermagnesemia in
[47, 48] and anti-inflammatory effects [49], to our
knowledge, no current data are available on the effects
of 5-HT7 receptor agonists/antagonists in serum electro-
lyte concentrations. Among these, the 5-HT7 receptor
subtype is the target of LP-211, a newly synthesized se-
lective agonist [50–52]. Therefore, in this manuscript,
for the first time, we attempt to investigate low-term ef-




All experimental protocols were approved by the local
animal care committee in accordance with Tehran Uni-
versity of Medical Sciences guidelines for the care and
use of laboratory animals. In the current study, 60 adult
male Wistar albino rats (Pasteur Institute, Tehran, Iran),
weighing 300–350 g with 7–8 weeks old were utilized.
The animals were kept in individual propylene cages
under standard laboratory conditions. Rats were main-
tained on a 12 h light/dark cycle at 23 ± 2 °C and 50 ±
5 % humidity. The animals were kept in standard room




azinehexanamide (SERVA Chemical Co., New York) was
dissolved in distilled water.





Successive doses (0.003–0.3 mg/kg, i.p.) were adminis-
tered cumulatively at short intervals (20 min maximum).
The drugs doses were in accordance with dosages deter-
mined in previous studies [52–54]. All drug solutions
were administered in a volume of 0.5 ml.
Laminectomy procedures
All surgery was carried out in sterilized condition. Ani-
mals were anesthetized by intraperitoneal injection of a
mixture of ketamine hydrochloride (75 mg/kg) and xyla-
zine hydrochloride (5 mg/kg). Their dorsal regions were
shaved and cleaned with povidone Iodine 10 %. Under
the sterile technique, after a dorsomedial incision on
skin, a laminectomy was performed between vertebral
levels T9–T11 to expose the underlying T10 spinal cord,
and the spinal cord was exposed microsurgically [9].
After the incision of the dermal and sub-dermal tissues
at the midline, paravertebral muscles were dissected
bluntly exposing the lamina bilaterally. Complete lamin-
ectomies were performed, exposing the spinal cord at
T9–T11. Strict bleeding control was performed using
bone wax and bipolar coagulator. The crushing or SCI
was produced by using the aneurysm clips (Yasargil FE
760) for 1 min with a closing force of 180 g on the spinal
cord at room temperature in T10 level [52, 53]. After
carefully removing the aneurysm clip, the fascia and the
skin were sutured separately using silk stitches. For the
sham-operated-operation, only the skin and muscles in
the thoracic vertebral level were removed but the dura
was kept intact. Following surgery and or/upon SCI, ani-
mals received antibiotics enrofloxacin 2.5 % intramuscu-
lar in the dose of 2.5 ml/Kg of body weight for three
days. Until termination of the experiment the welfare of
the rats was routinely checked. Furthermore, biochem-
ical analysis for the electrolytes ions was performed
14 days after SCI.
Experimental groups
The rats were randomly divided into six groups of ten as
follows:
Group 1: Intact (saline as vehicle): No SCI or treatment
was performed. Samples were obtained to determine
baseline biochemical values.
Group 2: Intact (LP-211): No SCI or treatment was
performed: samples were obtained to determine
baseline biochemical values.
Group 3: Sham-operated (laminectomy + vehicle): rats
underwent only a simple laminectomy. No SCI or
treatment was performed.
Group 4: Sham-operated (laminectomy + LP-211): rats
underwent a simple laminectomy and treatment. No




Group 5: Treatment (laminectomy + spinal trauma +
vehicle): Laminectomy and trauma was performed.
Rats received vehicle immediately following SCI.
Group 6: Treatment (laminectomy + spinal trauma +
LP-211): Laminectomy and trauma was performed.
Drugs were diluted with sterile saline and given
intraperitoneally (i.p.).
Assessment of biochemical analysis
All animals were anesthetized (ketamine hydrochloride
10 % + xylazine 2 %, in 80 and 5 mg/kg doses, respect-
ively). Blood samples were collected by cardiac puncture.
After this procedure, animals were sacrificed under keta-
mine–xylazine (KX) anesthesia.
For biochemical analyses, of blood was collected (5 ml),
in order to obtain serum samples. Serum was prepared
from whole blood without any anticoagulant. Plasma was
prepared from heparinized blood, separated by centrifuga-
tion at 1650 g for 10 min and stored at 4 °C for later use
(MSE Minor, England). Serum samples were separated
into the sterile plain tubes and stored in the refrigerator
for future analyses. All the analyses were completed within
48 h of the sample collection.
Serum electrolytes
Serum levels of Magnesium (Mg2+), Calcium (Ca2+), Iron
(Fe2+) and Phosphorus(P3−) were determined with the
aid of commercial kits from Wiener Lab and the BT
3000 Plus Analyzer. Sodium (Na+), Chlorine (Cl−), Po-
tassium (K+), Copper (Cu+), and Zinc (Zu+) levels were
determined using a Flame Photometer and analytical
standard ion solutions. The samples were diluted 100 ×
in Milli Q water.
Statistical analysis
The analyses were performed using SPSS (v. 18). The re-
sults are given as means ± SE. Differences between groups
were assessed using a one-way analysis of variance
(ANOVA) and followed by Tukey post test. The values of
P < 0.05, was considered statistically significant.
Results
The serum levels of Na+, K+ and Mg2+ are summarized
in Figs. 1, 2 and 3.
The Na+ levels were significantly higher in the intact
(saline) group compared with intact (LP-211) group (p <
0.001), SCI (saline), laminectomy (saline), laminectomy
(LP-211) and SCI (LP-211) groups (p < 0.001). Further-
more, the serum levels of Na+ in SCI (LP-211), laminec-
tomy (LP-211),and intact (LP-211) groups tended to be
lower than SCI (saline), laminectomy (saline) and intact
(saline) groups, respectively, the difference was statisti-
cally significance (P < 0.001). In addition, serum Na+




Fig. 1 Histogram comparing the effects of saline (vehicle) and LP-211 on serum sodium levels in rats. The data is expressed as mean ± standard
deviation (SD). Significantly different from intact ###(p < 0.001). Significantly different from laminectomy and SCI ***(p< 0.001). Statistical analysis
was performed by oneway ANOVA and Tukey post-hoc tests
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sham-operated) tended to be higher than in the treat-
ment groups, the difference was significant (P < 0.001).
Serum Na+ levels did significant differences compared
between the different groups. Additionally, the adminis-
tration of LP-211 significantly reduced the serum Na+
levels compared with the trauma, sham-operated, and




Fig. 2 Histogram comparing the effects of saline (vehicle) and LP-211 on pot
(SD). Significantly different from intact ###(p < 0.001). Significantly different from
performed by oneway ANOVA and Tukey post-hoc testsD A
K+ levels in the serum were found to be significantly
higher in the group SCI (LP-211), than the groups intact,
sham-operated, and SCI (saline) (p < 0.001). So that, in
the groups SCI (LP2-11) and intact (LP-211), there was
a significant increase in K+ levels of the serum when
compared to the groups SCI (saline) and intact (saline),
respectively. Moreover, in the group SCI (saline), activitiesassium levels in rats. The data is expressed as mean ± standard deviation




Fig. 3 Histogram comparing the effects of saline (vehicle) and LP-211 on magnesium levels in rats. The data is expressed as mean ± standard
deviation (SD). Significantly different from intact ###(p < 0.001).Significantly different from laminectomy and SCI ** (p < 0.01), ***(p < 0.001).
Furthermore, serum magnesium levels measured in the SCI (Saline) group was significantly higher than levels measured in laminectomy
(Saline) rats *(p < 0.05). Statistical analysis was performed by one-way ANOVA and Tukey post-hoc tests




of the potassium levels were found to be significantly
lower than in the group laminectomy (LP-211) (p < 0.01).
The differences were statistically very significant not only
between the groups SCI (LP-211) and laminectomy (sa-
line), but also between the groups intact (saline) and intact
(LP-211) (p < 0.001). Therefore, treatment with LP-211
significantly prevented the reduction of k+ levels in the
serum. On the other hand, LP-211 administration signifi-
cantly augmented the raises in the serum k+ levels, with
respect to control (Fig. 2).
On the other hand, serum Mg2+ levels were found to
be significantly increased in the trauma group when
compared with both the control and the sham-operated
groups (P < 0.001 for both). Nevertheless, Mg2+ level was
significantly higher in the SCI (LP-211) group than in
the intact and laminectomy groups (p < 0.001). And also,
it was significantly higher in SCI (saline) group than in
laminectomy (saline) group (p <0.05). It was also signifi-
cantly higher in the in laminectomy (LP-211) group than
in the SCI (saline) group (p < 0.01). Taken together, they
significantly decreased in the intact (saline), laminec-
tomy (saline) and intact (LP-211) groups compared to
the SCI (LP-211) group (p < 0.001), respectively. Expli-
citly, there was a significant difference in serum Mg2+
between the groups (P < 0.001) (Fig. 3). Finally, no sig-
nificant changes were found in the remaining deter-
mined electrolytes.
Discussion
This article emphasizes the major changes resulting
from alterations in plasma concentrations of sodium,
potassium, and magnesium after SCI. Moreover, weD A
showed for the first time that activating 5-HT7 receptor
by the 5-HT7 receptor agonist, LP-211, in experimental
model of SCI, exacerbates the metabolite imbalances
and elevated some serum electrolyte concentrations.
We observed significantly augmented severity of serum
electrolyte panel such as K+ and Mg+2 in rats that re-
ceived treatment. In our study, hypermagnesemia and
hyperkalemia were observed after spinal injury and LP-
211 enhances these changes.
We have determined the serum Mg2+ concentration
and demonstrate that following traumatic injury, serum
Mg2+ concentration increases and Mg2+ could affect a
number of factors thought to be involved in the second-
ary injury processes, including oxidative phosphorylation
[55], activity of excitatory amino acids [56], opiate recep-
tors [57], and eicosanoid synthesis [55]. Nevertheless,
the post-traumatic decline in Mg2+ may be a critical
early factor in the development of irreversible tissue
damage following SCI. Moreover, in agreement with our
data, several studies demonstrated that changes in potas-
sium are linked to the observed decrease/increase in
both total and free Mg2+ level. An association between
changes in K+ and Mg2+ has long been recognized, and
has been described in detail [58, 59], and these the
present study showed a hypermagnesemia and hyperka-
lemia after spinal injury.
Consistent with our study, spinal cord injury in rats
causes decreases in total tissue levels of Mg2+ and increase
in serum Mg2+ [60]. Similar to those described by Vink
et al., 1987 [61], it has found that traumatic SCI caused a
significant increase in extracellular free- Mg2+ concentra-
tion, and the decline in intracellular and it is highly




correlated to the severity of injury [62] and these changes
of Mg2+ may contribute to secondary tissue damage [63].
In conducted studies by Anderson et al. [64–66] re-
ported that laminectomy reduces spinal cord blood flow,
and Na+-K+/Mg2+ ATPase activity. Therefore, the hyper-
magnesemia and hyperkalemia levels in our study and
are in a good agreement.
Interactions between agonist and antagonist of 5-HT7
receptor, and their combined effects on neuronal func-
tion, have not been reported to the same extent as those
effects mediated by the actions of SCI on serotonergic
pathways. Nevertheless, recent studies with different recep-
tors of 5-HT has been shown to inhibit Na+/K+-ATPase
function; both indirectly, by phosphorylation of the
pump via 5-HT2c receptor activation in the choroid
plexus of the rat [67], and directly, after addition to iso-
lated Na+/K+-ATPase pump protein from the pig kid-
ney [68]. This premise was also supported by the
results of the present study. Moreover, studies have
shown high expression of 5-HT7 receptor transcripts in
pig cerebral blood vessels [69, 70], canine cerebral blood
vessels [71, 72], rat cerebral blood vessels [73–75], and
several human meningeal tissues, including the in-
ternal carotid and middle meningeal artery and smooth
muscles [76].
Acute LP-211 exposure at 0.3 mmol/L, did signifi-
cantly alter serum sodium, potassium and magnesium
concentrations and the remaining doses did not signifi-
cantly demonstrate decreased Na+-K+/Mg2+ ATPase
pump activity compared with the high doses. This may
reflect the fact that several steps contribute to regulation
of the Na+-K+/Mg2+ ATPase pump, from 5-HT reuptake
inhibition by LP-211 to 5-HT7 receptor activation and
involvement of multiple potential signal transduction
pathways. The LP-211-associated reduction in Na+/K+-
ATPase function may be caused by several factors, includ-
ing a decrease in the total number of Na+-K+/Mg2+
ATPase pump molecules and/or covalent modifications
that affect pump function. Therefore, translational or
post-translational changes, including covalent modifica-
tions of the Na+/K+-ATPase pump, also may contribute
to diminished pump function. Phosphorylation via acti-
vation of specific 5-HT receptors is one likely possibil-
ity [67]. The consequences, after short-term LP-211
treatment, of reduced Na+/K+-ATPase activity on neur-
onal function need to be examined. LP-211 may lead to
increased intracellular Na+ and extracellular K+/Mg2+
concentrations after acute exposure because of a decrease
and increase in removal of cytosolic Na+ and K+/Mg2+ by
the Na+/K+-ATPase pump, respectively. However, it is also
possible that the decrease in Na+/K+-ATPase pump func-
tion is a compensatory response to a reduced intracellular
Na+ and enhanced extracellular K+/Mg2+ concentrations




Measurement of the electrolytes content should help to
support either of these hypotheses. This reduction in
Na+/K+-ATPase function almost certainly will affect
cellular physiology. Experiments are now in progress to
determine the significance of these changes that occur
after short -term LP-211 treatment.
On the other hand, other investigations have shown
that serotonin plays important roles in various micro-
vascular responses after trauma to the cord including in-
crease and disturbances of microvascular permeability,
edema formation and reduction of blood flow [77–79].
Therefore it seems likely that the elevation of 5HT7 re-
ceptor accumulation in the traumatized cord in treated
animals with LP-211 may partly be responsible for some
of the harmful effects of the drug. Furthermore, multiple
studies have proposed that 5-HT contributes to the post-
traumatic decline of blood flow and edema seen in in-
jured spinal cords [80–83].
Conclusions
In summary, the data presented in this study show that
serum k+ and Mg2+ levels were increased by LP-211, and
the serum k+ and Mg2+ levels were higher in the LP-211
group compared with SCI with saline and sham-
operated groups (P < 0.001), and also, the serum Na+
levels were lower in the LP-211 group compared with
mentioned groups. We have hypothesized that this effect
is induced the inhibition of Na+-K+/Mg2+ ATPase activ-
ity by the increase in lipid peroxidation levels by SCI
and LP-211. The results of our study provided the first
experimental evidence of the serum biochemical events
of LP-211 in traumatic SCI. Therefore, in light of these
results, we believe that LP-211 may not be a potential
electroprotective agent for clinical trials of SCI.
To the best of our knowledge, the present study show-
ing the negative correlation between serum electrolyte
changes, SCI and LP-211 findings at comparison be-
tween groups, but future studies will be needed to reveal
important explanations for the questions about the de-
tails of LP-211 mechanisms in secondary injury after
spinal cord trauma on Na+- K+/Mg2+ ATPase activity
and in order to verify this correlation in detail.
Regarding the above information, it was shown that
even acute additive LP-211 treatments in the SCI group
led to hyponatremia, hyperkalemia and hypermagnese-
mia, it may be stated that LP-211 treatment as a promis-
ing candidate for treating SCI complications in some
body systems especially urinary tract might take into
consideration and further studies would be needed to
clarify its dose-dependent benefits or drawbacks and in
SCI patients. The observed discrepancies, nevertheless;
will also pose new questions. Altogether, this will ultim-
ately contribute to the further understanding of the patho-
physiological role due to 5-HT7 receptor activation.
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